Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
N WeisNiels Obel

Abstract

Coinfection with hepatitis C virus (HCV) in human immunodeficiency virus (HIV) type 1-infected patients may decrease the effectiveness of highly active antiretroviral therapy. We determined the impact of HCV infection on response to highly active antiretroviral therapy and outcome among Danish patients with HIV-1 infection. This prospective cohort study included all adult Danish HIV-1-infected patients who started highly active antiretroviral therapy from 1 January 1995 to 1 January 2004. Patients were classified as HCV positive (positive HCV serological test and/or HCV PCR results [443 patients [16%]]), HCV negative (consistent negative HCV serological test results [2183 patients [80%]]) and HCV-U (never tested for HCV [108 patients [4%]]). The study end points were viral load, CD4+ cell count, and mortality. Compared with the HCV-negative group, overall mortality was significantly higher in the HCV-positive group (mortality rate ratio, 2.4; 95% confidence interval [CI], 1.9-3.0), as was liver disease-related mortality (mortality rate ratio, 16; 95% CI, 7.2-33). Furthermore, patients in the HCV-positive group had a higher risk of dying with a prothrombin time <0.3, from acquired immunodeficiency syndrome-related disease, and i...Continue Reading

References

Mar 1, 1989·American Journal of Public Health·S Greenland
May 23, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H ZylberbergS Pol
Aug 5, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C T StaplesD Dudas
Jul 25, 2000·JAMA : the Journal of the American Medical Association·D L ThomasD Vlahov
Aug 2, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y BenhamouUNKNOWN MultivirC Group
Feb 8, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kenneth E ShermanNatasa Rajicic
Jul 4, 2002·JAMA : the Journal of the American Medical Association·Mark S SulkowskiDavid L Thomas
Oct 11, 2002·Archives of Internal Medicine·Andrea De LucaUNKNOWN Italian Cohort Naive Antiretrovirals Study Group
Dec 10, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Søren Jensen-FangelNiels Obel
Feb 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carmen Martinez-SierraJosé A Girón-González
Dec 4, 2004·AIDS·Eugènia Mariné-BarjoanUNKNOWN Registre des Ponctions-Biopsies Hépatiques
Jul 30, 2005·Scandinavian Journal of Infectious Diseases·Nicolai LohseNiels Obel
Aug 19, 2005·The Journal of Infectious Diseases·Jürgen K RockstrohUNKNOWN EuroSIDA Study Group

❮ Previous
Next ❯

Citations

Oct 13, 2006·Current HIV/AIDS Reports·Jeffrey J Weiss, Jack M Gorman
Apr 3, 2009·The New England Journal of Medicine·Mari M KitahataUNKNOWN NA-ACCORD Investigators
Dec 28, 2006·The Journal of Infectious Diseases·Ann-Brit Eg HansenNiels Obel
May 1, 2008·The Journal of Infectious Diseases·Andrea KovacsAlan Landay
Oct 7, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ole S SogaardNiels Obel
Oct 22, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ting-Yi ChenArthur Y Kim
Feb 16, 2010·The Journal of Infectious Diseases·Andrea KovacsLena Al-Harthi
Sep 19, 2008·International Journal of Epidemiology·Niels ObelHenrik T Sørensen
Jun 14, 2012·The Journal of Infectious Diseases·Maria C VillacresAlexandra M Levine
Dec 1, 2011·The Journal of Antimicrobial Chemotherapy·José A Pérez-MolinaSantiago Moreno
Sep 18, 2012·The Journal of Antimicrobial Chemotherapy·Liliana Elena WeimerUNKNOWN ISS-NIA Study Group
Nov 7, 2007·The Pediatric Infectious Disease Journal·Dariela MicheloudUNKNOWN Spanish Group of Pediatric HIV Infection
Dec 20, 2007·AIDS·Fiona M EwingsUNKNOWN UK Register of HIV Seroconverters
Jan 28, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Michael J FischerUNKNOWN VACS Project Team
Sep 7, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ali JuddUNKNOWN National Study of HIV in Pregnancy and Childhood (NSHPC)
Nov 30, 2013·Epidemiology and Infection·Z A ButtM Saeed
Dec 13, 2006·Expert Opinion on Investigational Drugs·Nafsika Georgopapadakou
Jul 17, 2010·AIDS Care·Katharine BreauxMaria C Rodriguez-Barradas
Mar 23, 2011·Bioscience Trends·N HeR Detels
Apr 4, 2007·Alcoholism, Clinical and Experimental Research·Debbie M ChengJeffrey H Samet
Mar 29, 2013·HIV Medicine·D GrintUNKNOWN EuroSIDA in EuroCoord (European Coordinating Committee for the Integration of Ongoing Coordination Actions Related to Clinic
Apr 16, 2013·Journal of Hepatology·Jürgen K RockstrohUNKNOWN EuroSIDA in EuroCoord
Jul 19, 2012·Scandinavian Journal of Infectious Diseases·Kristina ThorsteinssonAnne-Mette Lebech
Jun 11, 2015·AIDS Patient Care and STDs·Julia L MarcusMichael J Silverberg
Jul 31, 2014·International Journal of Epidemiology·Lars Haukali OmlandNiels Obel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.